Global Lung Cancer Diagnostic and Screening Market- Regional Analysis
Among regions, North America is estimated to hold a dominant position in the global lung cancer diagnostic and screening market over the forecast period. North America is estimated to hold 33.5% of the market share in 2023. The global lung cancer diagnostic and screening market is expected to witness significant growth in the coming years, driven by the high prevalence of lung cancer. The increasing prevalence of neurological disorders is contributing to the growth of the lung cancer diagnostic and screening market in the North America region. For instance, according to data published by the American Society of Clinical Oncology (ASCO) on March 3, 2023, worldwide, lung cancer is the second most commonly diagnosed cancer, while NSCLC (non-small cell lung cancer) is the most common type of lung cancer in the U.S., accounting for 81% of all lung cancer diagnoses.
Lung Cancer Diagnostic And Screening Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients